TD Waterhouse Canada’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.4K | Buy |
1,720
+600
| +54% | +$29.1K | ﹤0.01% | 1002 |
|
|
2025
Q1 | $37.1K | Buy |
1,120
+77
| +7% | +$2.55K | ﹤0.01% | 1149 |
|
|
2024
Q4 | $41.1K | Sell |
1,043
-268
| -20% | -$10.5K | ﹤0.01% | 1127 |
|
|
2024
Q3 | $59.7K | Hold |
1,311
| – | – | ﹤0.01% | 986 |
|
|
2024
Q2 | $70.7K | Buy |
1,311
+16
| +1% | +$863 | ﹤0.01% | 941 |
|
|
2024
Q1 | $85.3K | Sell |
1,295
-153
| -11% | -$10.1K | ﹤0.01% | 938 |
|
|
2023
Q4 | $90.7K | Sell |
1,448
-40
| -3% | -$2.51K | ﹤0.01% | 823 |
|
|
2023
Q3 | $65.7K | Sell |
1,488
-10
| -0.7% | -$441 | ﹤0.01% | 861 |
|
|
2023
Q2 | $87.3K | Sell |
1,498
-220
| -13% | -$12.8K | ﹤0.01% | 814 |
|
|
2023
Q1 | $80.5K | Sell |
1,718
-81
| -5% | -$3.8K | ﹤0.01% | 808 |
|
|
2022
Q4 | $76.4K | Sell |
1,799
-102
| -5% | -$4.33K | ﹤0.01% | 813 |
|
|
2022
Q3 | $128K | Sell |
1,901
-2,344
| -55% | -$157K | ﹤0.01% | 724 |
|
|
2022
Q2 | $273K | Buy |
4,245
+95
| +2% | +$6.12K | ﹤0.01% | 640 |
|
|
2022
Q1 | $277K | Buy |
4,150
+2,610
| +169% | +$174K | ﹤0.01% | 673 |
|
|
2021
Q4 | $115K | Buy |
+1,540
| New | +$115K | ﹤0.01% | 849 |
|